Abstract
Dilated cardiomyopathy is considered a disease of uncertain and probably heterogeneous origin, characterized by dilatation and impaired systolic function of the left or both ventricles [1]. Although this definition underscores the typical pathological aspect of dilated cardiomyopathy, there is increasing evidence that a larger spectrum of morphological conditions can be included in this unexplained heart muscle disease. In fact, patients with impairment of systolic function of unknown cause show a wide range of left ventricular dimensions, from very enlarged to absolutely normal chambers [2]. In the past, different studies attributed a prognostic significance to the degree of left ventricular dilatation, that was considered as one of the factors predicting mortality in patients with dilated cardiomyopathy [3–6]. However, other observations on small series have recently shown that patients with an idiopathic reduction of contractility may have an unfavorable outcome despite the absence of relevant left ventricular enlargement [7,8]. Moreover, a preliminary analysis of 144 patients enrolled in the SPIC (Italian Multicentric Study on Cardiomyopathies) Registry and followed up for about three years did not confirm the role of ventricular dilatation as an independent negative prognostic factor [9].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Report of the 1995 World Health Organization /International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies (1996) Circulation 93:841–842
Gavazzi A, De Maria R, Porcu, Beretta L, Casazza F, Castelli G, Luvini M, Parodi O, Recalcati F, Renosto G, Sinagra G, De Vita C, Camerini F, Baroldi G (1995) Cardiomiopatia dilatativa: una nuova storia naturale? L’esperienza dello Studio Italiano Policentrico Cardiomiopatie (SPIC). G Ital Cardiol 25:1109–1125
Komajda M, Jaist JP, Reeves F, Goldfarb B, Bouthour JB, Juillieres Y, Lanfranchi J, Peycelon P, Geslin PH, Carriett D, Grosgogeat Y (1990) Factors predicting mortality in idiopathic dilated cardiomyopaty. Eur Heart J 11:824–831
Diaz RA, Obasohan A, Oakley CM (1987) Prediction of outcome in dilated cardiomyopathy. Br Heart J 58:393–399
Gavazzi A, Lanzarini L, Cornalba C, Desperati M, Raisaro A, Angoli L, De Servi S, Specchia G (1984) Dilated (congestive) cardiomyopathy. Follow-up study of 137 patients. G Ital Cardiol 11:492–498
Di Lenarda A, Secoli G, Perkan A, Gregori D, Lardieri G, Pinamonti B, Sinagra G, Zecchin M, Camerini F and the Heart Muscle Disease Study Group (1994) Changing mortality in dilated cardiomyopathy. Br Heart J 72 [Suppl]:S46–S51
Keren A, Billingham ME, Weintraub D, Stinson EB, Popp RL (1985) Mildly dilated congestive cardiomyopathy. Circulation 72:302–309
Keren A, Gottlieb S, Tzivoni D, Yarom R, Billingham ME, Popp RL (1990) Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation 81:506–517
Gavazzi A, De Maria R, Renosto G, Moro A, Borgia M, Caroli A, Castelli G, Ciaccheri M, Pavan D, De Vita C, Baroldi G, Camerini F (1993) on behalf of the SPIC Group: The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. Am Heart J 125:410–422
Sahn DJ, De Maria AN, Kisslo J, Weyman A, (1976) The committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 58:1072–1083
Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EGJ, Schoen FJ (1986) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14
Hinkle L, Thaler J (1982) Clinical classification of cardiac deaths. Circulation 65:457–464
Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 23:1564–1575
Regan TJ (1990) Alcohol and the cardiovascular system. JAMA 264:377–38
Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320:409–415
Prazak P, Pfisterer M, Osswald S, Buser P, Burkart F (1996) Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J 17:251–257
De Maria R, Gavazzi A, Caroli A, Ometto R, Biagini A, Camerini F (1992) Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 69:1451–1457
Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355
Fuster V, Gersh BJ Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47:525–531
Ikram H, Williamson HG, Won IG, Wells EJ (1987) The course of idiopathic dilated cardiomyopathy in New Zealand. Br Heart J 57:521–517
Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H (1988) Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 116:1455–146
Author information
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Italia
About this paper
Cite this paper
Porcu, M., De Maria, R., Gavazzi, A., Italian Study Group on Cardiomyopathies (SPIC). (1998). Mildly Dilated Cardiomyopathy. In: Camerini, F., Gavazzi, A., De Maria, R. (eds) Advances in Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2155-6_24
Download citation
DOI: https://doi.org/10.1007/978-88-470-2155-6_24
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2181-5
Online ISBN: 978-88-470-2155-6
eBook Packages: Springer Book Archive